SBC Medical Group Holdings Inc

SBC Nasdaq CIK: 0001930313

Company Information

Industry Services-Offices & Clinics of Doctors of Medicine
SIC Code 8011
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 200 SPECTRUM CENTER DR., IRVINE, CA, 92618
Mailing Address 200 SPECTRUM CENTER DR., IRVINE, CA, 92618
Phone 9495930250
Fiscal Year End 1231
EIN 881263511

Financial Overview

FY2024

$46.61M
Net Income
$266.08M
Total Assets
$115.00M
Total Liabilities
$195.11M
Stockholders' Equity
$125.04M
Cash & Equivalents
$0.48
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events January 5, 2026 View on SEC
8-K Current report of material events December 31, 2025 View on SEC
S-3 Shelf registration for future offerings December 29, 2025 View on SEC
8-K Current report of material events December 15, 2025 View on SEC
8-K Current report of material events November 14, 2025 View on SEC
10-Q Quarterly financial report November 14, 2025 View on SEC
8-K Current report of material events November 13, 2025 View on SEC
8-K Current report of material events August 13, 2025 View on SEC
10-Q Quarterly financial report August 13, 2025 View on SEC
8-K Current report of material events July 17, 2025 View on SEC

Material Events

8-K Strategy Change January 5, 2026
High Impact
  • SBC Medical Group Holdings Inc. made a strategic minority investment in OrangeTwist, a U.S.-based MedSpa company.
  • The company established a partnership framework with OrangeTwist and its main investors.
View Analysis
8-K Acquisition December 15, 2025
High Impact
  • SBC Medical Group Holdings Inc., through its subsidiary SBC Medical Group Co., Ltd. (SBCMG), successfully acquired a controlling stake in Waqoo, Inc., a company listed on the Tokyo Stock Exchange Growth Market.
  • This acquisition significantly expands SBC Medical Group's presence and market share in the Japanese market.
View Analysis

Related Companies

Companies in the same industry (SIC: 8011)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.